ArticleJournal of family medicine and primary care2020
Preventive and treatment strategies of COVID-19: From community to clinical trials.
Article in Journal of family medicine and primary care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.Journal of translational medicine · 2024Pooled it
- Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19.Current stem cell research & therapy · 2024Review
- Socioeconomic and risk-related drivers of compliance with measures to prevent SARS-CoV-2 infection: evidence from the Munich-based KoCo19 study.BMC public health · 2023Article
- Global research on vitamin D and coronavirus disease 2019: A bibliometric and visualized study.Medicine · 2022Article
- A Look at COVID-19 Global Health Situation, 1-Year Post Declaration of the Pandemic.Microbiology insights · 2022Review
- Current Insights and Molecular Docking Studies of the Drugs under Clinical Trial as RdRp Inhibitors in COVID-19 Treatment.Current pharmaceutical design · 2022Article
- Role of ABO Blood Groups in Susceptibility and Severity of COVID-19 in the Georgian Population.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2022Article
- Article
- A review on how to do hematology consults during COVID-19 pandemic.Blood reviews · 2021Review
- Infection and disease spectrum in individuals with household exposure to SARS-CoV-2: A family cluster cohort study.Journal of medical virology · 2021Article
- The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes.Scientific reports · 2021Observational
- Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.Laboratory medicine · 2021Review
- Control and Prevention of the COVID-19 Epidemic in China: A Qualitative Community Case Study.Risk management and healthcare policy · 2021Article
- Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.Journal of inflammation research · 2021Review
- COVID-19: The Level of Knowledge, Anxiety and Symptom Presentation.Psychology research and behavior management · 2021Article
- SARS-CoV-2 replicating in nonprimate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals.Journal of medical virology · 2021Review
- Characteristics and Behaviors Associated with Prevalent SARS-CoV-2 Infection.International journal of general medicine · 2021Article
- SocioCultural and Religious Impacts Upon Covid-19 Pandemic Physical Distancing Public Practices.International journal of general medicine · 2021Article
- Epidemiological characterisation of asymptomatic carriers of COVID-19 in Colombia: a cross-sectional study.BMJ open · 2020Article
- Comparison between two different successful approaches to COVID-19 pandemic in India (Dharavi versus Kerala).Journal of family medicine and primary care · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The latest threat to global health is the form of the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. This new coronavirus (SARS-COV-2) started as a local outbreak in Wuhan, China but soon tightened its grip on human lives around the globe. So far, we do not have a particularly effective anti-SARS-COV-2 vaccine or antiviral agent against COVID-19. Across the globe, many research organizations such as the National Institutes of Health (NIH), United States are studying and testing various drugs and vaccines for their effectiveness against SARS-COV-2. Currently, the principle fighting tool being promoted by the World Health Organization (WHO) is the prevention of acquiring SARS-COV-2 infection by following basic health hygiene rules and social distancing. We hereby discuss major non-pharmacological and pharmacological interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.